Sign up Australia
Proactive Investors - Run By Investors For Investors

Novogen, Coretrack among Tuesday’s volume leaders

Novogen, Coretrack among Tuesday’s volume leaders

Tuesday’s leading volume stocks on the ASX.

Novogen Limited ASX:NRT $0.29 -30.1% 63,437,330
Coretrack Limited ASX:CKK $0.01 -9.1% 38,296,086
Axxis Technology Group ASX:AYG $0.001 -50% 29,860,746
Genetic Technologies ASX:GTG $0.042 -6.7% 25,631,735
Telstra Corporation ASX:TLS $6.19 0.3% 21,906,632
Fortescue Metals Group ASX:FMG $1.87 -1.1% 21,473,324
International Goldfields ASX:IGS $0.001 0% 17,500,000
SmartTrans Holdings ASX:SMA $0.023 9.5% 15,522,618
Environmental Clean Technologies ASX:ESI $0.011 10% 14,721,111
Stonehenge Metals ASX:SHE $0.029 -6.5% 14,649,339


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

View full NRT profile View Profile

Novogen Ltd Timeline

August 05 2015

Related Articles

PreveCeutical Medical bidding to be big player in preventive healthcare
October 11 2017
Van Deventer aims to grow the firm's valuation from its current $40mln market cap to $1bn plus in the next few years
Novogen: Access latest PPT from Proactive's CEO Sessions
April 13 2017
Dr James Garner talked clinical-stage programs with investors.
Paradigm Biopharmaceuticals: Access latest PPT from Proactive's CEO Sessions
May 19 2017
Paul Rennie talked timeline to clinical trial results with investors.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use